Programs that help smokers kick the habit along with existing lung cancer screening efforts could reduce lung cancer mortality by 14 percent compared with screening alone, according to a study led by the University of Michigan.
“The study shows the huge impact that combined screening/smoking cessation programs could have,” said senior author Dr. Rafael Meza, associate professor of epidemiology at the School of Public Health, and co-leader of the Cancer Epidemiology and Prevention Program at the University of Michigan Rogel Cancer Center.
“Smoking cessation interventions at the point of lung screening could result in many additional lung cancer deaths prevented and considerable life-years gained.”
Annual lung cancer screening with low-dose computed tomography (LDCT) is recommended for adults aged 55-80 with at least a 30-pack-a-year smoking history who currently smoke or have quit within the previous 15 years.
Since about 50 percent of screen-eligible individuals are still current smokers, cessation interventions at the point of screening are recommended. However, information about the short- and long-term effects of joint screening and cessation interventions is limited.Friday Letter Submission, Publish on March 27